The Coming Deluge of Cancer and Immune Erosion from the Pfizer Bioweapons | Guest: Dr. Jane Ruby | 3/1/22

The Coming Deluge of Cancer and Immune Erosio...

Up next

Stop Inflating Housing to Promote Baby Boomer Assets | 5/1/26

The political establishment and the media are lying to you about the housing crisis. It’s not a supply problem — it’s a government affordability problem fueled by asset bubbles, and the GOP is completely focused on the wrong things. In this Free-for-All Friday episode, I explain ...  Show more

The Farm Bill Scam: How Washington Destroyed Family Farms | 4/30/26

American family farms are being systematically destroyed by the very government bills claiming to protect them. I’m joined by fourth-generation farmer and Farm Action Fund President Joe Maxwell to expose the massive corporate monopolies, land-grabs, and venture socialism hidden i ...  Show more

Recommended Episodes

Covipod #9 : Le vaccin, moins efficace chez certaines personnes
Futura News

Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ...

  Show more

Third Vaccine On The Way, Fauci Hails 'Spectacular Results'
Consider This from NPR

A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ...  Show more

Coronapod: COVID boosters amidst global vaccine inequity
Nature Podcast

Several wealthy nations have announced plans to give third vaccine doses in a bid to help increase the protection of their most vulnerable citizens - but the science is not clear on whether this strategy will be effective or indeed necessary. Meanwhile with limited vaccine suppli ...  Show more

A Vaccine Breakthrough
The Daily

It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.

But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine ...

  Show more